Interestingly, the hepatic SIRT1-SREBP1c signaling pathway has been reported to play a crucial role in controlling hepatic lipid metabolism and thus promoting liver protection against NAFLD [148]. This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatotic liver disease.